En esta página
01TVTX precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
TVTX Travere Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 4, 2026
$56,93
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$23,00mínimo 52 semanas
$68,73máximo 52 semanas
Capitalización Bursátil (MRQ)
$5.36B
P/E (TTM)
-126.5
BPA (TTM)
$-0.45
Ingresos (TTM)
$591M
tus insignias
Rango 52S
$23–$69
Calificación del Analista
BUY
Precio Objetivo
$75
P/E
-126.5
ROE
-151.8%
Margen de Beneficio Neto
-7.4%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
TVTX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$56.93
Capitalización Bursátil (MRQ)
$5.36B
P/E (TTM)
-126.5
BPA (TTM)
$-0.45
Ingresos (TTM)
$591M
ROE (TTM)
-151.8%
Rango 52S
$23–$69
TVTX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$491M2016-12-31 → 2025-12-31
BPA$-0.292016-12-31 → 2025-12-31
Flujo de caja libre·2016-12-31 → 2023-12-31
Margen neto-7.4%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | TVTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -126.5promedio 5A ≈-31.4 | ≈-31.4 | · | · | |
| P/S (TTM) | 9.1promedio 5A ≈9.1 | ≈9.1 | 18.5 | Infravalorado | |
| P/C (MRQ) | 218.6promedio 5A ≈19.5 | ≈19.5 | 12.5 | Sobrevalorado | |
| Price / Cash Flow (Precio / Flujo de Caja) | 137.0promedio 5A ≈-11.1 | ≈-11.1 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | -50.1promedio 5A ≈1212.9 | ≈1212.9 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | TVTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -6.8%promedio 5A ≈-123.2% | ≈-123.2% | -24.1% | De primer nivel | |
| Margen EBITDA (TTM) | 3.9%promedio 5A ≈-106.2% | ≈-106.2% | -24.1% | De primer nivel | |
| Margen antes de impuestos (TTM) | -11.3%promedio 5A ≈-123.3% | ≈-123.3% | -28.9% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | -7.4%promedio 5A ≈-86.1% | ≈-86.1% | -38.1% | De primer nivel | |
| ROA (TTM) | -6.4%promedio 5A ≈-26.1% | ≈-26.1% | -23.8% | De primer nivel | |
| ROE (TTM) | -151.8%promedio 5A ≈-555.0% | ≈-555.0% | -35.7% | En línea | |
| ROIC | -55.8%promedio 5A ≈-294.8% | ≈-294.8% | -16.7% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | TVTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 4.0promedio 5A ≈3.3 | ≈3.3 | 8.3 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 1.1promedio 5A ≈0.8 | ≈0.8 | 3.2 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | TVTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 110.5%promedio 5A ≈30.6% | ≈30.6% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 64.9%promedio 5A ≈25.3% | ≈25.3% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 19.9% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | TVTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.8promedio 5A ≈0.4 | ≈0.4 | 0.0 | De primer nivel | |
| Inventory Turnover (Rotación de Inventario) | 0.3promedio 5A ≈1.0 | ≈1.0 | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 9.2promedio 5A ≈10.8 | ≈10.8 | 9.2 | En línea | |
| Revenue / Employee (Ingresos / Empleado) | ≈$987.4K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
67.9%
Próximo informe
Oct 28, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 4, 2026 | $-0.10 | $-0.14 | 29.3% |
| 31 de marzo de 2026 | $-0.40 | $-0.27 | -47.7% | |
| 31 de diciembre de 2025 | $0.03 | $-0.12 | 124.9% | |
| 30 de septiembre de 2025 | $0.28 | $-0.21 | 232.1% | |
| 30 de junio de 2025 | $-0.14 | $-0.30 | 53.9% | |
| 31 de marzo de 2025 | $-0.47 | $-0.55 | 14.7% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $491M | $233M | $145M | $109M | $132M | $198M | $175M | $164M | $155M | $134M | $100M | $28M | |
| Cost of Revenue | $10M | $8M | $11M | $4M | $4M | $6M | $5M | $6M | $4M | $5M | $2M | $571.0K | |
| R&D Expense | · | · | · | $8M | · | · | $141M | $124M | $78M | $71M | $50M | $48M | |
| SG&A Expense | $337M | $264M | $266M | $198M | $126M | $136M | $129M | $104M | $101M | $92M | $80M | $60M | |
| Operating Expenses | $554M | $557M | $533M | $429M | $331M | $374M | $313M | $244M | $209M | $192M | $151M | $108M | |
| Operating Income | $-63M | $-324M | $-388M | $-320M | $-199M | $-176M | $-137M | $-80M | $-54M | $-58M | $-51M | $-80M | |
| Interest Expense | · | · | $11M | $11M | $20M | $19M | $19M | $10M | $4M | $5M | $8M | $7M | |
| Interest Income | $13M | $18M | $22M | $6M | $2M | $5M | $10M | $5M | $3M | · | · | · | |
| Other Non-op | $12M | $-3M | $2M | $974.0K | $231.0K | $1M | $-314.0K | $-474.0K | $1M | $-264.0K | $-296.0K | $2M | |
| Pretax Income | $-49M | $-321M | $-376M | $-331M | $-217M | $-189M | $-146M | $-102M | $-58M | $-58M | $105M | $-113M | |
| Income Tax | $988.0K | $120.0K | $223.0K | $313.0K | $409.0K | $-19M | $-21.0K | $811.0K | $1M | $-10M | $-12M | $-2M | |
| Net Income | $-26M | $-322M | $-111M | $-278M | $-180M | $-169M | $-146M | $-103M | $-60M | $-48M | $117M | $-111M | |
| EPS (Basic) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 | $-3.56 | $-3.46 | $-2.54 | $-1.54 | $-1.29 | $3.49 | $-4.43 | |
| EPS (Diluted) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 | $-3.56 | $-3.46 | $-2.54 | $-1.54 | $-1.29 | $3.17 | $-4.43 | |
| Shares (Basic) | 89,211,813 | 78,888,861 | 74,267,418 | 63,758,515 | 59,832,287 | 47,539,631 | 42,339,961 | 40,433,171 | 38,769,816 | 36,997,865 | 33,560,249 | 25,057,509 | |
| Shares (Diluted) | 89,211,813 | 78,888,861 | 74,267,418 | 63,758,515 | 59,832,287 | 47,539,631 | 42,339,961 | 40,433,171 | 38,769,816 | 38,288,012 | 37,581,439 | 25,057,509 | |
| EBITDA | $-2M | $-280M | $-350M | $-233M | $-135M | $-152M | $-117M | $-61M | $-36M | $-42M | · | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $59M | $58M | $62M | $166M | $85M | $62M | $103M | $99M | $41M | $38M | $18M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $201M | $215M | $192M | $10M | |
| Receivables | $80M | $27M | $21M | $17M | $16M | $16M | $18M | $13M | $14M | $19M | $12M | $8M | |
| Inventory | $36M | $42M | $9M | $5M | $7M | $8M | $6M | $6M | $5M | $3M | $3M | $801.0K | |
| Prepaid Expense | $29M | $13M | $19M | $12M | $7M | $8M | $5M | $4M | $3M | $5M | $2M | $813.0K | |
| Current Assets | $438M | $417M | $617M | $486M | $583M | $410M | $429M | $496M | $326M | $332M | $302M | $37M | |
| PP&E (Net) | $4M | $5M | $7M | $9M | $11M | $9M | $3M | $3M | $3M | $3M | $428.0K | $671.0K | |
| PP&E (Gross) | $14M | $14M | $15M | $14M | $14M | $13M | $5M | $4M | $4M | $3M | · | · | |
| Accum. Depreciation | $10M | $9M | $7M | $5M | $3M | $4M | $2M | $1M | $585.0K | $200.0K | · | · | |
| Goodwill | · | $800.0K | $800.0K | $800.0K | $900.0K | $900.0K | $936.0K | $936.0K | $936.0K | $936.0K | $936.0K | $936.0K | |
| Intangibles | $114M | $104M | $104M | $97M | $148M | $154M | $157M | $187M | $185M | $182M | $162M | $94M | |
| Other Non-current Assets | $9M | $18M | $11M | $11M | $11M | $8M | $15M | $8M | $6M | $7M | $2M | $2M | |
| Total Assets | $605M | $594M | $789M | $673M | $777M | $607M | $605M | $709M | $520M | $525M | $512M | $135M | |
| Accounts Payable | $25M | $24M | $42M | $17M | $15M | $12M | $27M | $7M | $19M | $8M | $8M | $7M | |
| Accrued Liabilities | $126M | $86M | $119M | $96M | $75M | $57M | $52M | $50M | $36M | $33M | $24M | $28M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | $40M | |
| Current Liabilities | $160M | $201M | $178M | $142M | $124M | $93M | $95M | $105M | $86M | $83M | $87M | $108M | |
| Capital Leases | $11M | $17M | $23M | $28M | $31M | $28M | $7M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $6M | $24M | $141.0K | |
| Other Non-current Liabilities | $8M | $7M | $10M | $9M | $12M | $12M | $21M | $18M | $2M | $4M | $3M | $2M | |
| Total Liabilities | $490M | $535M | $588M | $630M | $475M | $396M | $384M | $391M | $227M | $218M | $212M | $173M | |
| Common Stock | $9.0K | $9.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | $1.59B | $1.51B | $1.33B | $1.06B | $1.07B | $798M | $637M | $590M | $472M | $421M | $366M | $141M | |
| Retained Earnings | $-1.47B | $-1.45B | $-1.13B | $-1.01B | $-766M | $-586M | $-416M | $-270M | $-178M | $-113M | $-65M | $-179M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $0 | $3M | |
| AOCI | $-1M | $-80.0K | $-1M | $-3M | $-562.0K | $-902.0K | $726.0K | $-2M | $-1M | $-490.0K | $-682.0K | $4M | |
| Stockholders' Equity | $115M | $59M | $201M | $43M | $302M | $211M | $221M | $318M | $293M | $308M | $300M | $-37M | |
| Liabilities + Equity | $605M | $594M | $789M | $673M | $777M | $607M | $605M | $709M | $520M | $525M | $512M | $135M | |
| Shares Outstanding | 90,922,868 | 87,452,835 | 75,367,117 | 64,290,570 | 62,491,498 | 52,248,431 | 43,088,921 | 41,389,524 | 39,373,745 | 37,906,669 | 36,465,853 | 26,048,480 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $61M | $44M | $39M | $21M | $13M | $25M | $20M | $19M | $18M | $16M | $13M | $5M | |
| Stock-based Comp | $45M | $37M | $44M | $38M | $30M | $24M | $21M | $20M | $27M | $29M | $26M | $16M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-6M | $-23M | $-16M | $-2M | |
| Amort. of Intangibles | $59M | $42M | $36M | $19M | $11M | $22M | $20M | $18M | $17M | $16M | $13M | $5M | |
| Restructuring | $0 | $2M | $11M | $0 | $0 | $0 | $0 | $-242.0K | $4M | $893.0K | $0 | · | |
| Other Non-cash | $-42M | $4M | $-251M | $20M | $108M | $78M | $47M | $39M | $29M | $24M | · | · | |
| Operating Cash Flow | $38M | $-237M | $-280M | $-186M | $-15M | $-43M | $-58M | $-25M | $7M | $-3M | $-1M | $-46M | |
| CapEx | · | · | $668.0K | $191.0K | $5M | $7M | $195.0K | $727.0K | $887.0K | $1M | $22.0K | $663.0K | |
| Investing Cash Flow | $28M | $99M | $56M | $-33M | $-138M | $-61M | $20M | $-203M | $46M | $10M | $-81M | · | |
| Net Debt Issued | · | · | · | · | · | $0 | $0 | $-40M | · | · | · | · | |
| Stock Issued | $0 | $135M | $191M | $0 | $189M | · | · | · | $0 | $0 | $149M | $40M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $0 | $0 | $2M | |
| Net Stock Activity | $0 | $135M | $191M | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $-33M | $139M | $219M | $118M | $232M | $128M | $-2M | $232M | $5M | $-4M | $102M | $95M | |
| Net Change in Cash | $34M | $359.0K | $-4M | $-104M | $81M | $22M | $-40M | $3M | $58M | $3M | $20M | $12M | |
| Taxes Paid | · | $453.0K | $578.0K | $996.0K | $-16M | $-3M | $656.0K | $218.0K | · | · | · | · | |
| Free Cash Flow | · | · | $-281M | $-186M | $-20M | $-50M | $-58M | $-26M | $7M | $-3M | · | · | |
| Levered FCF | · | · | $-292M | $-198M | $-40M | $-67M | $-77M | $-36M | $5M | $-4M | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.8% | -138.9% | -267.2% | -125.7% | -71.1% | -88.8% | -78.3% | -48.7% | -34.7% | -43.6% | · | · | |
| Net Margin | -5.2% | -137.9% | -76.7% | -131.3% | -79.2% | -85.4% | -83.5% | -62.5% | -38.6% | -35.9% | · | · | |
| Pretax Margin | -10.0% | -137.5% | -259.0% | -131.2% | -79.0% | -95.2% | -83.5% | -62.0% | -37.7% | -43.1% | · | · | |
| EBITDA Margin | -0.42% | -120.2% | -240.7% | -110.1% | -59.4% | -76.4% | -66.7% | -37.4% | -23.2% | -31.5% | · | · | |
| ROA | -4.3% | -46.5% | -15.2% | -38.4% | -26.0% | -28.0% | -22.3% | -16.7% | · | -9.2% | · | · | |
| ROE | -34.6% | -2246.8% | -46.4% | -388.1% | -59.1% | -66.1% | -62.7% | -32.2% | · | -15.8% | · | · | |
| ROIC | -55.8% | -548.4% | -193.4% | -622.8% | -53.7% | -74.9% | -62.1% | -25.4% | · | -15.7% | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.1 | 3.5 | 3.4 | 4.7 | 4.4 | 4.5 | 4.7 | · | 4.0 | · | · | |
| Quick Ratio | 1.1 | 0.4 | 0.4 | 0.6 | 1.5 | 1.1 | 0.8 | 1.1 | · | 3.3 | · | · | |
| Interest Coverage | · | · | -34.3 | -23.6 | -8.0 | -9.2 | -7.3 | -8.2 | -44.8 | -72.8 | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | |
| Inventory Turnover | 0.3 | 1.0 | 1.6 | 1.1 | 0.9 | 0.9 | 0.9 | 1.0 | · | 1.7 | · | · | |
| Receivables Turnover | 9.2 | 9.7 | 7.7 | 13.0 | 14.3 | 11.7 | 11.4 | 11.6 | · | 8.6 | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.26 | $0.68 | $2.66 | $0.67 | $4.83 | $4.04 | $5.13 | $7.69 | · | $8.12 | · | · | |
| Revenue / Share | $5.50 | $2.96 | $1.96 | $3.33 | $3.80 | · | · | $4.06 | $4.00 | $3.49 | · | · | |
| Cash Flow / Share | $0.42 | $-3.01 | $-3.77 | $-2.92 | $-0.25 | · | · | $-0.62 | $0.19 | $-0.04 | · | · | |
| Cash / Share | $1.02 | $0.67 | $0.77 | $0.96 | $2.65 | $1.62 | $1.45 | $2.49 | · | $1.08 | · | · | |
| EPS (TTM) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 | $-3.56 | $-3.46 | $-2.54 | $-1.54 | $-1.29 | $3.17 | $-4.43 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 110.5% | 60.6% | 32.7% | -17.0% | -33.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 64.9% | 20.9% | -9.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.9% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $491M | $233M | $145M | $109M | $132M | $198M | $175M | $164M | $155M | $134M | $100M | $28M | |
| Net Income TTM | $-26M | $-322M | $-111M | $-278M | $-180M | $-169M | $-146M | $-103M | $-60M | $-48M | $117M | $-111M | |
| Market Cap | $3.47B | $1.52B | $678M | $1.35B | $1.94B | $1.42B | $612M | $937M | · | $718M | · | · | |
| P/E | -131.8 | -4.3 | -6.0 | -4.8 | -10.3 | -7.7 | -4.1 | -8.9 | -13.7 | -14.7 | 6.1 | -2.8 | |
| P/S | 7.1 | 6.5 | 4.7 | 12.4 | 14.7 | 7.2 | 3.5 | 5.7 | · | 5.4 | · | · | |
| P/B | 30.3 | 25.8 | 3.4 | 31.6 | 6.4 | 6.7 | 2.8 | 2.9 | · | 2.3 | · | · | |
| P / Tangible Book | 3618.9 | · | 7.1 | · | 12.7 | 25.3 | · | · | · | · | · | · | |
| P / Cash Flow | 91.9 | -6.4 | -2.4 | -7.3 | -131.1 | -33.3 | -10.5 | -37.5 | · | -449.6 | · | · | |
| P / FCF | · | · | -2.4 | -7.3 | -97.5 | -28.8 | -10.5 | -36.5 | · | -237.3 | · | · | |
| Earnings Yield | -0.76% | -23.4% | -16.7% | -20.8% | -9.7% | -13.1% | -24.4% | -11.2% | -7.3% | -6.8% | 16.4% | -36.2% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $127M | $130M | $165M | $114M | $82M | $75M | $63M | $54M | $41M | $45M | $37M | $32M | $31M | $-21M | $28M | |
| Cost of Revenue | $2M | $2M | $3M | $2M | $2M | $5M | $3M | $2M | $2M | $2M | $5M | $1M | $1M | $4M | $-883.0K | $1M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $8M | · | · | |
| SG&A Expense | $96M | $80M | $102M | $86M | $63M | $60M | $70M | $66M | $65M | $64M | $64M | $68M | $68M | $66M | $45M | $52M | |
| Operating Expenses | $166M | $164M | $162M | $140M | $127M | $124M | $136M | $119M | $122M | $181M | $139M | $130M | $136M | $128M | $84M | $111M | |
| Operating Income | $4M | $-37M | $-32M | $25M | $-13M | $-43M | $-61M | $-56M | $-68M | $-139M | $-94M | $-93M | $-104M | $-97M | $-106M | $-83M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $3M | $3M | · | $3M | |
| Interest Income | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | |
| Other Non-op | $-169.0K | $-91.0K | $11M | $487.0K | $-526.0K | $549.0K | $-581.0K | $520.0K | $-3M | $238.0K | $1M | $335.0K | $-201.0K | $87.0K | $872.0K | $-586.0K | |
| Pretax Income | $-35M | $-37M | $-21M | $26M | $-13M | $-41M | $-60M | $-55M | $-70M | $-136M | $-89M | $-89M | $-102M | $-96M | $-104M | $-84M | |
| Income Tax | $-204.0K | $-120.0K | $921.0K | $8.0K | $20.0K | $39.0K | $-72.0K | $-84.0K | $85.0K | $191.0K | $68.0K | $12.0K | $65.0K | $78.0K | $63.0K | $145.0K | |
| Net Income | $-35M | $-37M | $3M | $26M | $-13M | $-41M | $-60M | $-55M | $-70M | $-136M | $-90M | $151M | $-86M | $-86M | $-66M | $-70M | |
| EPS (Basic) | $-0.37 | $-0.40 | $0.03 | $0.29 | $-0.14 | $-0.47 | $-0.71 | $-0.70 | $-0.91 | $-1.76 | $-1.07 | $1.97 | $-1.13 | $-1.27 | $-1.03 | $-1.09 | |
| EPS (Diluted) | $-0.37 | $-0.40 | $0.04 | $0.28 | $-0.14 | $-0.47 | $-0.71 | $-0.70 | $-0.91 | $-1.76 | $-1.07 | $1.97 | $-1.13 | $-1.27 | $-1.03 | $-1.09 | |
| Shares (Basic) | 93,479,416 | 91,868,862 | · | 89,230,420 | 88,945,624 | 88,355,973 | · | 77,779,379 | 77,500,245 | 77,136,493 | · | 76,305,603 | 76,001,801 | 68,174,099 | · | 64,033,759 | |
| Shares (Diluted) | 93,479,416 | 91,868,862 | · | 102,618,560 | 88,945,624 | 88,355,973 | · | 77,779,379 | 77,500,245 | 77,136,493 | · | 76,305,603 | 76,001,801 | 68,174,099 | · | 64,033,759 | |
| EBITDA | $4M | $-12M | · | $25M | $-13M | $-30M | · | $-56M | $-68M | $-129M | · | $-93M | $-88M | $-78M | · | $-68M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $118M | $78M | $93M | $111M | $75M | $62M | $59M | $36M | $32M | $43M | · | $144M | $71M | $161M | · | $151M | |
| Receivables | $81M | $87M | $80M | $83M | $39M | $34M | $27M | $25M | $24M | $23M | · | $15M | $20M | $22M | · | $13M | |
| Inventory | $40M | $37M | $36M | $38M | $38M | $38M | $42M | $43M | $43M | $42M | · | $21M | $19M | $7M | · | $7M | |
| Prepaid Expense | $37M | $34M | $29M | $28M | $17M | $14M | $13M | $16M | $13M | $13M | · | $16M | $12M | $15M | · | $9M | |
| Current Assets | $615M | $393M | $438M | $371M | $380M | $374M | $417M | $325M | $369M | $481M | · | $686M | $542M | $605M | · | $535M | |
| PP&E (Net) | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $7M | · | $8M | $9M | $9M | · | $10M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | · | $800.0K | $800.0K | $800.0K | · | $800.0K | $800.0K | $800.0K | · | $800.0K | $900.0K | $900.0K | · | $900.0K | |
| Intangibles | $132M | $110M | $114M | $109M | $106M | $104M | $104M | $104M | $105M | $101M | · | $107M | $154M | $163M | · | $149M | |
| Other Non-current Assets | $9M | $8M | $9M | $10M | $20M | $19M | $18M | $17M | $17M | $19M | · | $13M | $12M | $11M | · | $11M | |
| Total Assets | $799M | $555M | $605M | $539M | $555M | $549M | $594M | $504M | $551M | $664M | · | $833M | $736M | $808M | · | $726M | |
| Accounts Payable | $7M | $13M | $25M | $18M | $19M | $15M | $24M | $23M | $26M | $17M | · | $25M | $20M | $17M | · | $14M | |
| Accrued Liabilities | $136M | $104M | $126M | $106M | $82M | $77M | $86M | $84M | $80M | $140M | · | $96M | $89M | $86M | · | $88M | |
| Current Liabilities | $152M | $125M | $160M | $135M | $190M | $182M | $201M | $190M | $121M | $173M | · | $139M | $136M | $131M | · | $131M | |
| Capital Leases | $8M | $10M | $11M | $13M | $14M | $16M | $17M | $19M | $20M | $21M | · | $24M | $25M | $26M | · | $28M | |
| Other Non-current Liabilities | $12M | $9M | $8M | $6M | $8M | $7M | $7M | $16M | $17M | $16M | · | $8M | $9M | $9M | · | $9M | |
| Total Liabilities | $775M | $456M | $490M | $465M | $523M | $516M | $535M | $535M | $536M | $589M | · | $553M | $620M | $619M | · | $626M | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | · | $7.0K | $7.0K | $7.0K | · | $6.0K | |
| Paid-in Capital | $1.57B | $1.61B | $1.59B | $1.55B | $1.53B | $1.52B | $1.51B | $1.36B | $1.35B | $1.34B | · | $1.32B | $1.31B | $1.29B | · | $1.05B | |
| Retained Earnings | $-1.54B | $-1.51B | $-1.47B | $-1.48B | $-1.50B | $-1.49B | $-1.45B | $-1.39B | $-1.33B | $-1.26B | · | $-1.04B | $-1.19B | $-1.10B | · | $-948M | |
| AOCI | $-1M | $-1M | $-1M | $-1M | $-812.0K | $-843.0K | $-80.0K | $-1M | $-2M | $-2M | · | $-4M | $-4M | $-2M | · | $303.0K | |
| Stockholders' Equity | $25M | $99M | $115M | $74M | $33M | $33M | $59M | $-30M | $15M | $74M | $201M | $280M | $116M | $189M | $43M | $101M | |
| Liabilities + Equity | $799M | $555M | $605M | $539M | $555M | $549M | $594M | $504M | $551M | $664M | · | $833M | $736M | $808M | · | $726M | |
| Shares Outstanding | 94,174,767 | 92,403,744 | 90,922,868 | 89,456,626 | 89,102,347 | 88,787,429 | 87,452,835 | 77,909,042 | 76,456,562 | 76,108,829 | · | 75,111,517 | 74,971,807 | 74,586,806 | · | 64,150,510 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $25M | $18M | $16M | $14M | $13M | $12M | $11M | $10M | $10M | $9M | $6M | $8M | $7M | $6M | $-793.0K | |
| Stock-based Comp | $22M | $16M | $11M | $11M | $11M | $11M | $9M | $8M | $10M | $10M | $8M | $11M | $11M | $13M | $9M | $8M | |
| Amort. of Intangibles | $4M | $25M | $18M | $15M | $14M | $12M | $12M | $11M | $10M | $9M | $9M | $11M | $10M | $6M | $-603.0K | $5M | |
| Restructuring | · | · | $0 | $0 | $0 | $0 | $1M | $123.0K | $653.0K | $259.0K | $11M | $0 | $0 | $0 | · | · | |
| Other Non-cash | · | $-45M | · | · | · | $-25M | · | · | · | $-3M | · | · | · | $-18M | · | · | |
| Operating Cash Flow | $58M | $-40M | $61M | $14M | $5M | $-42M | $-36M | $-43M | $-40M | $-119M | $-70M | $-59M | $-69M | $-81M | $-55M | $-40M | |
| CapEx | · | · | · | $140.0K | · | · | · | $0 | $82.0K | $0 | · | $10.0K | $3.0K | $630.0K | · | $13.0K | |
| Investing Cash Flow | $-206M | $22M | $-105M | $87M | $5M | $41M | $-80M | $46M | $29M | $105M | $-17M | $133M | $-24M | $-37M | $-37M | $10M | |
| Financing Cash Flow | $188M | $4M | $27M | $-65M | $1M | $4M | $139M | $46.0K | $782.0K | $-525.0K | $124.0K | $-634.0K | $2M | $217M | $551.0K | $2M | |
| Net Change in Cash | $39M | $-15M | $-18M | $36M | $13M | $3M | $22M | $4M | $-11M | $-15M | $-86M | $73M | $-91M | $100M | $-90M | $-28M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-119M | · | · | · | $-82M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-122M | · | · | · | $-85M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.3% | -29.0% | · | 15.1% | -11.1% | -52.2% | · | -89.3% | -125.1% | -336.5% | · | -249.6% | -146.7% | -152.7% | · | -127.4% | |
| Net Margin | -20.5% | -29.2% | · | 15.6% | -11.1% | -50.4% | · | -87.1% | -130.1% | -328.9% | · | 406.4% | -143.4% | -151.5% | · | -130.2% | |
| Pretax Margin | -20.6% | -28.9% | · | 15.6% | -11.1% | -50.4% | · | -87.2% | -128.6% | -328.1% | · | -240.5% | -143.3% | -151.3% | · | -129.9% | |
| EBITDA Margin | 2.3% | -9.2% | · | 15.1% | -11.1% | -36.5% | · | -89.3% | -125.1% | -312.6% | · | -249.6% | -146.7% | -136.0% | · | -127.4% | |
| ROA | -5.1% | -6.7% | · | 4.9% | -2.3% | -6.8% | · | -8.2% | -10.9% | -18.5% | · | 19.3% | -11.3% | -10.5% | · | -9.3% | |
| ROE | -121.5% | -56.4% | · | 119.3% | -53.3% | -77.1% | · | -44.0% | -107.0% | -103.4% | · | 79.2% | -62.7% | -43.5% | · | -34.1% | |
| ROIC | 16.0% | -37.3% | · | 33.9% | -38.7% | -130.1% | · | 184.1% | -447.5% | -188.2% | · | -33.1% | -75.2% | -46.1% | · | -67.8% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.0 | 3.1 | · | 2.7 | 2.0 | 2.1 | · | 1.7 | 3.0 | 2.8 | · | 4.9 | 4.0 | 4.6 | · | 4.1 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.4 | 0.6 | 0.5 | · | 0.3 | 0.5 | 0.4 | · | 1.1 | 0.7 | 1.4 | · | 1.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -49.7 | · | -33.1 | -30.2 | -30.0 | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.8 | · | 0.2 | |
| Receivables Turnover | 2.8 | 2.1 | · | 3.0 | 3.6 | 2.9 | · | 3.2 | 2.4 | 1.9 | · | 2.7 | 3.2 | 3.1 | · | 4.1 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.26 | $1.07 | · | $0.82 | $0.37 | $0.37 | · | $-0.39 | $0.20 | $0.97 | · | $3.72 | $1.55 | $2.54 | · | $1.57 | |
| Revenue / Share | $1.81 | $1.38 | · | $1.61 | $1.29 | $0.93 | · | $0.81 | $0.70 | $0.54 | · | $0.49 | $0.79 | $0.84 | · | $0.84 | |
| Cash Flow / Share | · | $-0.44 | · | · | · | $-0.48 | · | · | · | $-1.54 | · | · | · | $-1.19 | · | · | |
| Cash / Share | $1.25 | $0.85 | · | $1.24 | $0.84 | $0.70 | · | $0.47 | $0.42 | $0.57 | · | $1.92 | $0.95 | $2.16 | · | $2.36 | |
| EPS (TTM) | $-0.45 | $-0.22 | · | $-1.04 | $-2.02 | $-2.79 | · | $-4.44 | $-1.77 | $-1.99 | · | $-1.46 | $-4.52 | $-4.44 | · | $-4.16 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $591M | $536M | · | $436M | $334M | $274M | · | $203M | $178M | $156M | · | $79M | $70M | $66M | · | $42M | |
| Net Income TTM | $-43M | $-21M | · | $-89M | $-169M | $-227M | · | $-351M | $-146M | $-161M | · | $-87M | $-307M | $-289M | · | $-264M | |
| Market Cap | $5.35B | $2.75B | · | $2.14B | $1.32B | $1.59B | · | $1.09B | $628M | $587M | · | $671M | $1.15B | $1.68B | · | $1.58B | |
| P/E | -126.2 | -135.0 | · | -23.0 | -7.3 | -6.4 | · | -3.2 | -4.6 | -3.9 | · | -6.1 | -3.4 | -5.1 | · | -5.9 | |
| P/S | 9.0 | 5.1 | · | 4.9 | 3.9 | 5.8 | · | 5.4 | 3.5 | 3.8 | · | 8.5 | 16.5 | 25.3 | · | 37.9 | |
| P/B | 218.2 | 27.8 | · | 29.1 | 40.3 | 48.5 | · | -35.8 | 41.5 | 7.9 | · | 2.4 | 9.9 | 8.9 | · | 15.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 3.9 | · | 66.2 | · | · | |
| P / Cash Flow | · | -68.0 | · | · | · | -37.7 | · | · | · | -4.9 | · | · | · | -20.7 | · | · | |
| Earnings Yield | -0.79% | -0.74% | · | -4.3% | -13.7% | -15.6% | · | -31.7% | -21.5% | -25.8% | · | -16.3% | -29.4% | -19.7% | · | -16.9% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $491M | $233M | $145M | $109M | $132M |
| Margen Operativo % | -12.8% | -138.9% | -267.2% | -125.7% | -71.1% |
| Beneficio neto | $-26M | $-322M | $-111M | $-278M | $-180M |
| EPS Diluido | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 2.7 | 2.1 | 3.5 | 3.4 | 4.7 |
| Ratio Rápido | 1.1 | 0.4 | 0.4 | 0.6 | 1.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | · | $-281M | $-186M | $-20M |
Propietarios institucionales (13F) 340 declarantes · $5.9B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
340
Valor en tenencia
$5.9B
Nuevas posiciones
91
Posiciones cerradas
27
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 91 (+38 vs trimestre anterior) | 27 (-28 vs trimestre anterior) | 123 (+28 vs trimestre anterior) | 89 (-10 vs trimestre anterior) | -9.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $455 653 851 | 8 020 663 | 7,74% | Acciones |
| FMR LLC | $403 158 609 | 7 096 614 | 6,84% | Acciones |
| JANUS HENDERSON GROUP PLC | $339 246 615 | 11 419 586 | 5,76% | Acciones |
| BANK OF AMERICA CORP /DE/ | $259 527 476 | 4 568 341 | 4,41% | Acciones |
| STATE STREET CORP | $241 796 085 | 4 256 224 | 4,10% | Acciones |
| VANGUARD GROUP INC | $241 075 642 | 6 309 229 | 4,09% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $233 414 906 | 4 108 694 | 3,96% | Acciones |
| PERCEPTIVE ADVISORS LLC | $213 183 729 | 3 752 574 | 3,62% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $159 779 000 | 2 812 514 | 2,71% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $145 965 114 | 2 569 356 | 2,48% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $134 773 950 | 2 371 887 | 2,29% | Acciones |
| Rock Springs Capital Management LP | $123 792 910 | 2 179 069 | 2,10% | Acciones |
| Kynam Capital Management, LP | $113 620 000 | 2 000 000 | 1,93% | Acciones |
| Stephens Investment Management Group LLC | $106 536 020 | 1 875 304 | 1,81% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $104 137 218 | 1 833 079 | 1,77% | Acciones |
| EMERALD ADVISERS, LLC | $90 946 334 | 1 600 886 | 1,54% | Acciones |
| ARMISTICE CAPITAL, LLC | $89 335 941 | 1 572 539 | 1,52% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $88 944 917 | 1 565 656 | 1,51% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $87 579 262 | 1 541 617 | 1,49% | Acciones |
| GOLDMAN SACHS GROUP INC | $87 221 587 | 1 535 321 | 1,48% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $87 094 276 | 1 533 080 | 1,48% | Acciones |
| Qube Research & Technologies Ltd | $81 989 896 | 1 443 230 | 1,39% | Acciones |
| D. E. Shaw & Co., Inc. | $81 833 044 | 1 440 469 | 1,39% | Acciones |
| Driehaus Capital Management LLC | $81 757 203 | 1 439 134 | 1,39% | Acciones |
| MARSHALL WACE, LLP | $75 739 490 | 1 333 207 | 1,29% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $65 726 898 | 1 156 960 | 1,12% | Acciones |
| MPM BIOIMPACT LLC | $63 782 348 | 1 122 731 | 1,08% | Acciones |
| Nuveen, LLC | $59 913 701 | 1 054 633 | 1,02% | Acciones |
| EMERALD MUTUAL FUND ADVISERS TRUST | $58 629 283 | 1 032 024 | 1,00% | Acciones |
| JANE STREET GROUP, LLC | $53 327 491 | 938 699 | 0,91% | Acciones |
| NORTHERN TRUST CORP | $49 709 205 | 875 008 | 0,84% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $46 997 663 | 827 278 | 0,80% | Acciones |
| Eversept Partners, LP | $45 389 656 | 798 973 | 0,77% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $37 598 221 | 661 824 | 0,64% | Acciones |
| Ensign Peak Advisors, Inc | $33 621 010 | 591 815 | 0,57% | Acciones |
| Fiera Capital Corp | $29 370 599 | 516 997 | 0,50% | Acciones |
| ARMISTICE CAPITAL, LLC | $28 405 000 | 500 000 | 0,48% | Opción de compra |
| PANAGORA ASSET MANAGEMENT INC | $27 878 030 | 490 724 | 0,47% | Acciones |
| TWO SIGMA ADVISERS, LP | $27 721 355 | 725 500 | 0,47% | Acciones |
| Point72 Asset Management, L.P. | $27 204 037 | 478 860 | 0,46% | Acciones |
| UBS Group AG | $26 897 036 | 473 456 | 0,46% | Acciones |
| LOOMIS SAYLES & CO L P | $26 752 625 | 470 914 | 0,45% | Acciones |
| Legal & General Group Plc | $26 723 424 | 470 400 | 0,45% | Acciones |
| Candriam S.C.A. | $26 690 051 | 470 265 | 0,45% | Acciones |
| Invesco Ltd. | $26 093 685 | 459 315 | 0,44% | Acciones |
| Graham Capital Management, L.P. | $25 376 800 | 446 696 | 0,43% | Acciones |
| MORGAN STANLEY | $24 385 926 | 429 253 | 0,41% | Acciones |
| Assenagon Asset Management S.A. | $24 275 197 | 427 305 | 0,41% | Acciones |
| Russell Investments Group, Ltd. | $22 495 038 | 395 969 | 0,38% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $22 131 322 | 379 611 | 0,38% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Opaleye L.P ×3 presentaciones | 5 de junio de 2015 | · | Presentación inicial | · | SEC |
| MSMB Capital Management LP, MSMB Capital Management LLC, MSMB Healthcare LP, MSMB Healthcare Investors LLC, MSMB Healthcare Management LLC, Martin Shkreli ×2 presentaciones | 19 de febrero de 2013 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 29 insiders · 14 directivos · 13 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Eric M Dube | CHIEF EXECUTIVE OFFICER | 17 de septiembre de 2026 M | 432 886 | 0 | 21 | $-41 345 901 |
| Christopher R. Cline | CHIEF FINANCIAL OFFICER | 15 de septiembre de 2026 M | 87 508 | 0 | 15 | $-4 644 621 |
| Laura Clague | Chief Financial Officer | 11 de mayo de 2022 S | 35 655 | 0 | 0 | $0 |
| Marc L Panoff | Chief Financial Officer | 24 de febrero de 2014 A | 221 100 | 0 | 0 | $0 |
| Neil F. Mcfarlane | Chief Operating Officer | 16 de mayo de 2019 S | 26 988 | 0 | 0 | $0 |
| Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | 17 de septiembre de 2026 M | 117 066 | 0 | 13 | $-18 970 991 |
| William E. Rote | Chief Research Officer | 16 de septiembre de 2026 M | 98 197 | 0 | 10 | $-16 427 375 |
| Jula Inrig | EVP, Head of R&D & CMO | 15 de septiembre de 2026 M | 100 491 | 0 | 15 | $-5 155 138 |
| Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 15 de septiembre de 2026 M | 42 353 | 0 | 8 | $-4 193 777 |
| Elizabeth E Reed | Chief Legal Officer and GC | 15 de septiembre de 2026 M | 105 389 | 0 | 19 | $-7 016 278 |
| Noah L. Rosenberg | Chief Medical Officer | 17 de agosto de 2021 S | 47 614 | 0 | 0 | $0 |
| Alvin Shih | EVP of Research & Development | 1 de septiembre de 2016 S | 158 334 | 0 | 0 | $0 |
| VALEUR JENSEN MARGARET E | General Counsel | 1 de febrero de 2016 A | 100 000 | 0 | 0 | $0 |
| Horacio Plotkin | Chief Medical Officer | 12 de diciembre de 2014 S | 91 767 | 0 | 0 | $0 |
| Jeffery A. Meckler | Consejero | 10 de septiembre de 2026 M | 91 500 | 0 | 5 | $-1 706 062 |
| LYONS GARY A | Consejero | 18 de agosto de 2026 M | 61 500 | 0 | 6 | $-961 428 |
| Roy D. Baynes | Consejero | 12 de junio de 2026 M | 41 500 | 0 | 6 | $-2 548 200 |
| Timothy Coughlin | Consejero | 12 de junio de 2026 M | 56 250 | 0 | 3 | $-1 272 582 |
| Sandra Poole | Consejero | 19 de mayo de 2026 A | 34 000 | 0 | 0 | $0 |
| Suzanne Louise Bruhn | Consejero | 19 de mayo de 2026 A | 32 750 | 0 | 0 | $0 |
| John A Orwin | Consejero | 19 de mayo de 2026 A | 39 375 | 0 | 0 | $0 |
| Ron Squarer | Consejero | 19 de mayo de 2026 A | 39 375 | 0 | 0 | $0 |
| Steve Aselage | Consejero | 11 de mayo de 2022 S | 146 919 | 0 | 0 | $0 |
| John W Kozarich | Consejero | 8 de mayo de 2019 A | 29 000 | 0 | 0 | $0 |
| Steven Gary Richardson | Consejero | 21 de noviembre de 2014 P | 129 165 | 0 | 0 | $0 |
| Jeffrey Paley | Consejero | 14 de agosto de 2014 S | 51 665 | 0 | 0 | $0 |
| Ruth Williams Brinkley | · | 19 de mayo de 2026 A | 29 750 | 0 | 0 | $0 |
| Cornelius E Golding | · | 18 de mayo de 2016 A | 29 000 | 0 | 0 | $0 |
| Martin Shkreli | · | 12 de septiembre de 2014 J | 1 765 168 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 40 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,76% | 266 816 SH | 2 de octubre de 2026 | Diario |
| SPIT · RBB Fund, Inc. | 2,66% | 15 858 NS | 31 de julio de 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 2,29% | 116 008 SH | 2 de octubre de 2026 | Diario |
| BBP · ETFis Series Trust I | 1,48% | 26 078 NS | 31 de julio de 2026 | N-PORT |
| GURU · Global X Funds | 1,42% | 15 557 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,82% | 72 196 NS | 31 de julio de 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,81% | 37 745 SH | 2 de octubre de 2026 | Diario |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,67% | 154 467 NS | 31 de julio de 2026 | N-PORT |
| SAWS · ETF Series Solutions | 0,58% | 810 NS | 31 de julio de 2026 | N-PORT |
| BRNY · EA Series Trust | 0,49% | 51 173 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,45% | 691 376 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,40% | 839 091 SH | 11 de septiembre de 2026 | Diario |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,39% | 27 839 SH | 2 de octubre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,36% | 6 674 SH | 2 de octubre de 2026 | Diario |
| ESSC · Strategy Shares | 0,31% | 2 023 NS | 31 de julio de 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,31% | 76 777 NS | 31 de julio de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,30% | 95 695 SH | 19 de agosto de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,23% | 986 NS | 31 de julio de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,22% | 3 427 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,21% | 29 359 SH | 11 de septiembre de 2026 | Diario |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 25 221 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,20% | 2 285 414 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,16% | 42 807 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,15% | 514 614 SH | 19 de agosto de 2026 | Diario |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,14% | 13 993 NS | 31 de julio de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 37 027 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,11% | 49 748 SH | 2 de octubre de 2026 | Diario |
| ESML · iShares Trust | 0,10% | 40 314 SH | 11 de septiembre de 2026 | Diario |
| FBCG · FIDELITY COVINGTON TRUST | 0,09% | 105 982 NS | 31 de julio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,07% | 249 426 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 39 446 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,06% | 1 066 102 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,05% | 4 919 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 2 948 502 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 7 348 SH | 19 de agosto de 2026 | Diario |
| ITOT · iShares Trust | 0,01% | 124 076 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,01% | 22 530 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,01% | 2 004 NS | 31 de julio de 2026 | N-PORT |
| ISCB · iShares Trust | · | 4 157 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 46 599 SH | 11 de septiembre de 2026 | Diario |
TVTX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 21 analistas
COMPRA
Objetivo mediano
$75.50
+32,6%
8 38,1%
Compra fuerte
11 52,4%
Compra
2 9,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
14 analistas · 2026-10-02Objetivo medio $75.21 +32,1%
← Por Debajo de Todos los Objetivos
Precio Actual $56.93
Mín$62.00
Media$75.21
Máx$90.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| KOD | $1.73B | -6.5 | · | · | -202.0% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 4, 2026